Author:
Igawa Mikio,Kadena Hitoshi,Ueda Mitsutaka,Usui Tsuguru
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference17 articles.
1. De Vere White RW, Meyers FJ (1988) Impact of chemotherapy on the treatment of bladder cancer. Probl Urol 2:413
2. Freiha F, De Vries C, Torti F (1988) Neoadjuvant and adjuvant chemotherapy of transitional cell carcinoma of the urothelium with cisplatin, methotrexate and vinblastine. World J Urol 6:153
3. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L (1988) Effect of granulocyte colonystimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414
4. Harker WG, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM, Torti FM (1985) Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: a Northern California Oncology Group study. J Clin Oncol 3:1463
5. Harmer MH (1978) TNM classification of malignant tumours, 3rd edn. International Union Against Cancer, Geneva